Ethypharm in licensing deal with Shantha Biotechnics

26 Feb 2007

1

Mumbai: French pharmaceutical company Ethypharm has entered into a licensing and supply agreement with Hyderabad-based Shantha Biotechnics for marketing an anti-nausea drug in India.

As per the agreement, Ethypharma would supply Ondansetron from its manufacturing facility near Mumbai, which would be marketed and distributed by Shantha Biotechnics in India , Ethypharm said in a statement.

Ondansetron is used to prevent nausea and vomiting associated with chemotherapy, certain radiotherapies, and the prevention of postoperative nausea or vomiting.

Patients who have difficulty with swallowing or who are not able to drink use Ondansetron Flashtab.

"Introduction of Ondansetron Flashtab showcases our strength in developing innovative solutions in the fast growing NDDS segment," Ajey Kumar, chief executive, Ethypharm India, said in the statement.

Indian companies are increasingly exploring alliances to enlarge their market. Shantha Biotechnics with assistance from the Centre for Cellular and Molecular Biology, launched India's first recombinant vaccine for Hepatitis B called Shanvac in 1997.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more